Human Insulin Market

  • Published on 2025-11-11
  • Report Code: 366
  • 150 pages
Human Insulin Market

Global Human Insulin Market: Market Segments: By Product (HI Drugs [HI Analogs, HI Biologics], HI Delivery Devices [Syringes, Pens, Pen Needles, and Pumps]); By Application (Type II Diabetes, Type I Diabetes, Gestational Diabetes & Prediabetes);and Region - Analysis of Market Size, Share & Trends for 2014 - 2019 and Forecasts to 2030

Table Of Content

Contents          

  1. Executive Summary
  2. Global Human Insulin Market
    1. Product Overview
    2. Market Definition
    3. Segmentation
    4. Assumptions and Acronyms
  3. Research Methodology
    1. Research Objectives
    2. Primary Research
    3. Secondary Research
    4. Forecast Model
    5. Market Size Estimation
  4. Average Pricing Analysis
  5. Macro-Economic Indicators
  6. Market Dynamics
    1. Growth Drivers
    2. Restraints
    3. Opportunity
    4. Trends
  7. Correlation & Regression Analysis
    1. Correlation Matrix
    2. Regression Matrix
  8. Recent Development, Policies & Regulatory Landscape
  9. Risk Analysis
    1. Demand Risk Analysis
    2. Supply Risk Analysis
  10. Global Human Insulin Market Analysis
    1. Porters Five Forces
      1. The threat of New Entrants
      2. Bargaining Power of Suppliers
      3. Threat of Substitutes
      4. Rivalry
    2. PEST Analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
  11. Global Human Insulin Market
    1. Market Size & forecast, 2019A-2030F
      1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  12. Global Human Insulin Market: Market Segmentation
    1. By Regions
    2. By Regions
      1. North America:(U.S. and Canada)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
        • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    3. By Product: Market Share (2020-2030F)
      1. HI Drugs, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. HI Delivery Devices, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
    4. By Application: Market Share (2020-2030F)
      1. Type II Diabetes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      2. Type I Diabetes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
      3. Gestational Diabetes & Prediabetes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
  1. Company Profile
    1. B. Braun Melsungen AG.
      1. Company Overview
      2. Company Total Revenue (Financials)
      3. Market Potential
      4. Global Presence
      5. Key Performance Indicators
      6. SWOT Analysis
      7. Product Launch
    2. ALBIREO PHARMA, INC
    3. BECTON, DICKINSON AND COMPANY
    4. BIOCON LIMITED
    5. Sanofi Aventis
    6. WOCKHARDT LIMITED
    7. JULPHAR
    8. YPSOMED HOLDING AG
    9. ELI LILLY AND COMPANY
    10. NOVO Nordisk A/S
    11. ADOCIA
    12. Tonghua Dongbao Pharmaceutical Co., LTD
    13. GSK
    14. Gulf Pharmaceutical Industries
    15. Medtronic PLC
    16. Oramed Pharmaceuticals, Inc
    17. SemBioSys Genetics
    18. Pfizer, Inc.
    19. Merck & Co., Inc.
    20. Other Prominent Players

Consultant Recommendation

**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients